Evidence map›Paper›PMID 27113466›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2016

International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.

Marianne J Hjermstad, Mia Bergenmar, Kristin Bjordal, Sheila E Fisher, Dirk Hofmeister, Sébastien Montel, Ourania Nicolatou-Galitis, Monica Pinto, Judith Raber-Durlacher, Susanne Singer and 7 more

2 registry-linked trialsAbstract readClinical Trial, Phase III
PubMed Publisher
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01724333 completednot on this map

International Validation and Testing of a Supplementary Questionnaire Module for Assessment of Oral and Dental Health in Cancer; the QLQ-OH17

TypeobservationalSponsorOslo University HospitalRan2012 to 2015Enrolled585ConditionsQuality of Life, Adverse Effects, Late Effects, Cancer
NCT04932317 completednot on this mapstarted 2021, after this paper: background citation

Oral Symptom Assessment Scale (OSAS): Validity and Reliability

TypeobservationalSponsorOur Lady's Hospice and Care ServicesRan2021 to 2022Enrolled54ConditionsNeoplasms
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. The effect of hematopoietic stem cell transplantation on patient-reported subjective oral dryness: a systematic review focusing on prevalence, severity and distress.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Pooled it
  3. MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Guideline
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Supportive care for talquetamab-related dysgeusia in multiple myeloma: mixed-methods evidence, nutrition-focused flowchart, and digital companion concept.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  9. Validation of the Japanese oral symptom assessment scale (OSAS-J) in patients with advanced cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  10. Article
  11. Oral health-related quality of life among long-term head and neck cancer survivors: a multinational study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  12. Article
  13. Observational
  14. Self-perceived oral health in hemato-oncological patients and the relation to quality of life.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  15. Article
  16. Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  17. The Oral Symptom Assessment Scale (OSAS): criterion validation with the EORTC QLQ-OH15 and reliability testing.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Marianne J HjermstadRegional Centre for Excellence in Palliative Care, Department of Oncology, Oslo University Hospital, Oslo, Norway. marianne.j.hjermstad@ntnu.no.
Mia BergenmarDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Kristin BjordalOslo University Hospital, Oslo, Norway.
Sheila E FisherUniversity of Leeds, Leeds, LS2 9JT, UK.
Dirk HofmeisterUniversity of Leipzig, Leipzig, Germany.
Sébastien MontelDepartment of Psychology, University Paris Saint Denis, Paris, France.
Ourania Nicolatou-GalitisUniversity of Athens, Athens, Greece.
Monica PintoRehabilitation Unit, Department of Quality of Life, Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Naples, Italy.
Judith Raber-DurlacherDepartment of Oral and Maxillofacial Surgery, Academic Medical Center University of Amsterdam, Amsterdam, Netherlands.
Susanne SingerInstitute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Mainz, Germany.
Iwona M TomaszewskaDepartment of Medical Education, Jagiellonian University Medical College, Krakow, Poland.
Krzysztof A TomaszewskiDepartment of Anatomy, Jagiellonian University Medical College, Krakow, Poland.
Irma Verdonck-de LeeuwDepartment of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, Netherlands.
Noam YaromDepartment of Oral and Maxillofacial Surgery, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Julie B WinstanleyPatricia Ritchie Centre, University of Sydney, Sydney, Australia.
Bente B HerlofsonDepartment of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Oslo, Norway.
EORTC QoL Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis international EORTC validation study (phase IV) is aimed at testing the psychometric properties of a quality of life (QoL) module related to oral health problems in cancer patients.

methodsThe phase III module comprised 17 items with four hypothesized multi-item scales and three single items. In phase IV, patients with mixed cancers, in different treatment phases from 10 countries completed the EORTC QLQ-C30, the QLQ-OH module, and a debriefing interview. The hypothesized structure was tested using combinations of classical test theory and item response theory, following EORTC guidelines. Test-retest assessments and responsiveness to change analysis (RCA) were performed after 2 weeks.

resultsFive hundred seventy-two patients (median age 60.3, 54 % females) were analyzed. Completion took <10 min for 84 %, 40 % expressed satisfaction that these issues were addressed. Analyses suggested a revision of the phase III hypothesized scale structure. Two items were deleted based on a high degree of item misfit, together with negative patient feedback. The remaining 15 items formed one eight-item scale named OH-QoL score, a two-item information scale, a two-item scale regarding dentures, and three single items (sticky saliva/mouth soreness/sensitivity to food/drink). Face and convergent validity and internal consistency were confirmed. Test-retest reliability (n = 60) was demonstrated as was RCA for patients undergoing chemotherapy (n = 117; p = 0.06). The resulting QLQ-OH15 discriminated between clinically distinct patient groups, e.g., low performance status vs. higher (p < 000.1), and head-and-neck cancer versus other cancers (p < 0.03).

conclusionThe EORTC module QLQ-OH15 is a short, well-accepted assessment tool focusing on oral problems and QoL to improve clinical management.

trial registrationClinicalTrials.gov Identifier: NCT01724333.

Indexed as

AdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedOral HealthPsychometricsQuality of LifeSurveys and QuestionnairesValidation Studies as TopicYoung AdultEORTC QLQ-C30Oral healthPatient reported outcomesQLQ-OH15Quality of lifeValidation study

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.